Cargando…

Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer

Immune checkpoint inhibitor (ICI) treatment has been used to treat advanced urothelial cancer. Molecular markers might improve risk stratification and prediction of ICI benefit for urothelial cancer patients. We analyzed 406 cases of bladder urothelial cancer from The Cancer Genome Atlas (TCGA) data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Pengju, Hao, Shihui, Ye, Yongkang, Wei, Jinhuan, Tang, Yiming, Tan, Lei, Liao, Zhuangyao, Zhang, Mingxiao, Li, Jiaying, Gui, Chengpeng, Xiao, Jiefei, Huang, Yong, Chen, Xu, Cao, Jiazheng, Luo, Junhang, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012532/ https://www.ncbi.nlm.nih.gov/pubmed/33816497 http://dx.doi.org/10.3389/fcell.2021.646982

Ejemplares similares

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma
por: Liao, Zhuangyao, et al.
Publicado: (2021)

The impact of tumor size on the survival of patients with small renal masses: A population–based study
por: Tang, Yiming, et al.
Publicado: (2022)

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)

Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer
por: Zeng, Dongqiang, et al.
Publicado: (2020)

SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients
por: Li, Pengju, et al.
Publicado: (2020)

Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape
por: Gui, Chengpeng, et al.
Publicado: (2023)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma
por: Huang, Yong, et al.
Publicado: (2018)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival
por: Fang, Yong, et al.
Publicado: (2013)

Localization of external urethral orifice in coronary sulcus during urethroplasty in case of severe hypospadias accompanied by prostatic utricle cyst
por: Lu, Jun, et al.
Publicado: (2021)

EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1
por: Pan, Yihui, et al.
Publicado: (2023)

Predictive Model for Systemic Infection After Percutaneous Nephrolithotomy and Related Factors Analysis
por: Tang, Yiming, et al.
Publicado: (2021)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma
por: Lin, Hansen, et al.
Publicado: (2023)

A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study
por: Huang, Yong, et al.
Publicado: (2019)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Impact of Age on the Cancer-Specific Survival of Patients with Localized Renal Cell Carcinoma: Martingale Residual and Competing Risks Analysis
por: Cai, Muyan, et al.
Publicado: (2012)

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer
por: Jiao, Xi, et al.
Publicado: (2021)

The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
por: Li, Tianhang, et al.
Publicado: (2023)

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
por: Yi, Ruibin, et al.
Publicado: (2022)

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
por: Sun, Ran, et al.
Publicado: (2022)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer
por: Zhou, Xinwei, et al.
Publicado: (2023)

Advanced Flow Cytometry Analysis Algorithms for Optimizing the Detection of “Different From Normal” Immunophenotypes in Acute Myeloid Blasts
por: Aanei, Carmen-Mariana, et al.
Publicado: (2021)

Construction and Validation of a Novel Pyroptosis-Related Gene Signature to Predict the Prognosis of Uveal Melanoma
por: Cao, Yuan, et al.
Publicado: (2021)

Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database
por: Tan, Zhiping, et al.
Publicado: (2023)

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
por: Yang, Li, et al.
Publicado: (2021)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rehvu2ab4jevom88v9nrdkqbsv